Overview

Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of combination chemotherapy in treating patients with advanced prostate cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Herbert Irving Comprehensive Cancer Center
Treatments:
Docetaxel
Estramustine
Mitoxantrone
Prednisone